pubmed-article:11262586 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11262586 | lifeskim:mentions | umls-concept:C0021853 | lld:lifeskim |
pubmed-article:11262586 | lifeskim:mentions | umls-concept:C0038463 | lld:lifeskim |
pubmed-article:11262586 | lifeskim:mentions | umls-concept:C0031164 | lld:lifeskim |
pubmed-article:11262586 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:11262586 | pubmed:dateCreated | 2001-3-23 | lld:pubmed |
pubmed-article:11262586 | pubmed:abstractText | The objective of the present study was to assess intestinal permeability in patients with infection caused by Strongyloides stercoralis. Twenty-six patients (16 women and 10 men), mean age 45.9, with a diagnosis of strongyloidiasis were evaluated. For comparison, 25 healthy volunteers (18 women and 7 men), mean age 44.9, without digestive disorders or intestinal parasites served as normal controls. Intestinal permeability was measured on the basis of urinary radioactivity levels during the 24 h following oral administration of chromium-labeled ethylenediaminetetraacetic acid ((51)Cr-EDTA) expressed as percentage of the ingested dose. The urinary excretion of (51)Cr-EDTA was significantly reduced in patients with strongyloidiasis compared to controls (1.60 +/- 0.74 and 3.10 +/- 1.40, respectively, P = 0.0001). Intestinal permeability is diminished in strongyloidiasis. Abnormalities in mucus secretion and intestinal motility and loss of macromolecules could explain the impaired intestinal permeability. | lld:pubmed |
pubmed-article:11262586 | pubmed:language | eng | lld:pubmed |
pubmed-article:11262586 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11262586 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11262586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11262586 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11262586 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11262586 | pubmed:month | Mar | lld:pubmed |
pubmed-article:11262586 | pubmed:issn | 0100-879X | lld:pubmed |
pubmed-article:11262586 | pubmed:author | pubmed-author:LaudannaA AAA | lld:pubmed |
pubmed-article:11262586 | pubmed:author | pubmed-author:SipahiA MAM | lld:pubmed |
pubmed-article:11262586 | pubmed:author | pubmed-author:IriyaKK | lld:pubmed |
pubmed-article:11262586 | pubmed:author | pubmed-author:DamiãoA OAO | lld:pubmed |
pubmed-article:11262586 | pubmed:author | pubmed-author:Werneck-Silva... | lld:pubmed |
pubmed-article:11262586 | pubmed:author | pubmed-author:BuchpigueC... | lld:pubmed |
pubmed-article:11262586 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11262586 | pubmed:volume | 34 | lld:pubmed |
pubmed-article:11262586 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11262586 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11262586 | pubmed:pagination | 353-7 | lld:pubmed |
pubmed-article:11262586 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:meshHeading | pubmed-meshheading:11262586... | lld:pubmed |
pubmed-article:11262586 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11262586 | pubmed:articleTitle | Intestinal permeability in strongyloidiasis. | lld:pubmed |
pubmed-article:11262586 | pubmed:affiliation | Laboratório de Investigação Médica (LIM 07), Departamento de Gastroenterologia, Hospital das Clínicas, Universidade de São Paulo, São Paulo, SP, Brasil. | lld:pubmed |
pubmed-article:11262586 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11262586 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |